USA Today reports:
People age 50 and up are now eligible for a second booster dose of COVID-19 vaccine at least four months after their first, the Food and Drug Administration said Tuesday.
“Based on an analysis of emerging data, a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine could help increase protection levels for these higher-risk individuals,” Dr. Peter Marks, who directs the FDA’s Center for Biologics Evaluation and Research, said in a statement.
For the Pfizer-BioNTech vaccine, the booster will be identical to all previous shots, while with Moderna, a booster contains half the original 100-microgram dose.
Read the full article.
Today, @US_FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. More details in our press release. ?https://t.co/kn77R0LXxz
— Michael Felberbaum (@FDASpox) March 29, 2022